Biblio Discovery — Demo Discovery Service

19 results for "Ida Gregersen"

Showing 1–19 · 1.97 seconds · RSS

  1. Journal Article

    IL-18 and IL-18 binding protein are related to disease severity and parasitemia during falciparum malaria

    Kari Otterdal; Aase Berg; Annika E. Michelsen et al.

    BMC Infectious Diseases, Vol. 21 No. 1 · 2021 · English · DOAJ Scopus

    Abstract Background Several inflammatory molecules participate in the immune response to malaria. Interleukin (IL)-18 is an inflammatory cytokine activated by NLRP3 inflammasomes. In clinical falciparum malaria, with and without HIV co-infection, data on IL-18 and in particular on its binding…

  2. Journal Article Full text

    Vitamin C Deficiency May Delay Diet-Induced NASH Regression in the Guinea Pig

    Josephine Skat-Rørdam; Kamilla Pedersen; Gry Freja Skovsted et al.

    Antioxidants, Vol. 11 No. 1 · 2021 · English · DOAJ Scopus

    Oxidative stress is directly linked to non-alcoholic fatty liver disease (NAFLD) and the progression to steaotohepatitis (NASH). Thus, a beneficial role of antioxidants in delaying disease progression and/or accelerating recovery may be expected, as corroborated by recommendations of, e.g., vitamin…

  3. Journal Article

    Plasma soluble TIM-3 is increased in normoglycemic South Asian women compared to Nordic women after gestational diabetes mellitus and associated with markers of metaflammation

    Helene Grannes; Archana Sharma; Anita Suntharalingam et al.

    Heliyon, Vol. 10 No. 22 · 2024 · English · DOAJ Scopus

    Background: Women with South Asian ethnicity have a higher risk of developing type 2 diabetes mellitus (T2DM) compared with white women of European descent, especially after gestational diabetes mellitus (GDM). Central obesity and adipose tissue dysfunction have been linked to their higher risk of…

  4. Journal Article

    Plasma levels of interleukin 27 in falciparum malaria is increased independently of co-infection with HIV: potential immune-regulatory role during malaria

    Kari Otterdal; Aase Berg; Annika E. Michelsen et al.

    BMC Infectious Diseases, Vol. 20 No. 1 · 2020 · English · DOAJ Scopus

    Abstract Background The immune response during falciparum malaria mediates both harmful and protective effects on the host; however the participating molecules have not been fully defined. Interleukin (IL)-27 is a pleiotropic cytokine exerting both inflammatory and anti-inflammatory effects, but…

  5. Journal Article Full text

    Increased Systemic and Local Interleukin 9 Levels in Patients with Carotid and Coronary Atherosclerosis

    Ida Gregersen; Mona Skjelland; Sverre Holm et al.

    PLoS ONE, Vol. 8 No. 8 · 2013 · English · PLOS Scopus

    Objective: Atherosclerosis is a chronic inflammatory disorder that involves a range of inflammatory mediators. Although interleukin (IL)-9 has been related to inflammation, there are at present no data on its role in atherosclerosis. Here we have examined IL-9 and IL-9 receptor (IL-9R) systemically…

    Also available at: DOAJ

  6. Journal Article Full text

    Interleukin 27 is increased in carotid atherosclerosis and promotes NLRP3 inflammasome activation

    Ida Gregersen; Øystein Sandanger; Erik T. Askevold et al.

    PLOS ONE, Vol. 12 No. 11 · 2017 · English · PLOS Scopus

    Aim: Interleukin-27 (IL-27) is involved in different inflammatory diseases; however, its role in atherosclerosis is unclear. In this study we investigated the expression of IL-27 and its receptor in patients with carotid atherosclerosis and if IL-27 could modulate the inflammatory effects of the…

    Also available at: DOAJ

  7. Journal Article

    Liraglutide and not lifestyle intervention reduces soluble CD163 after comparable weight loss in obese participants with prediabetes or type 2 diabetes mellitus

    Helene Grannes; Thor Ueland; Paola Simeone et al.

    Cardiovascular Diabetology, Vol. 23 No. 1 · 2024 · English · DOAJ Scopus

    Abstract Background The GLP-1 receptor agonist liraglutide is used to treat hyperglycemia in type 2 diabetes but is also known to induce weight loss, preserve the beta cell and reduce cardiovascular risk. The mechanisms underlying these effects are however still not completely known. Herein we…

  8. Journal Article

    Early increase of specialized pro-resolving lipid mediators in patients with ST-elevation myocardial infarctionResearch in context

    Linn E. Fosshaug; Romain A. Colas; Anne K. Anstensrud et al.

    EBioMedicine, Vol. 46 · 2019 · English · DOAJ Scopus

    Background: Termination of acute inflammation is an active process orchestrated by lipid mediators (LM) derived from polyunsaturated fatty acids, referred to as specialized pro-resolving mediators (SPM). These mediators also provide novel therapeutic opportunities for treating inflammatory disease…

  9. Journal Article

    NEIL3-deficient bone marrow displays decreased hematopoietic capacity and reduced telomere length

    Tom Rune Karlsen; Maria B. Olsen; Xiang Y. Kong et al.

    Biochemistry and Biophysics Reports, Vol. 29 · 2022 · English · DOAJ Scopus

    Deficiency of NEIL3, a DNA repair enzyme, has significant impact on mouse physiology, including vascular biology and gut health, processes related to aging. Leukocyte telomere length (LTL) is suggested as a marker of biological aging, and shortened LTL is associated with increased risk of…

  10. Journal Article

    Increased Levels of Lectin‐Like Oxidized Low‐Density Lipoprotein Receptor‐1 in Ischemic Stroke and Transient Ischemic Attack

    Tonje Skarpengland; Mona Skjelland; Xiang Yi Kong et al.

    Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol. 7 No. 2 · 2018 · English · DOAJ Scopus

    Background Soluble lectin‐like oxidized low‐density lipoprotein receptor‐1 (sLOX‐1) has been shown to be increased in patients with acute ischemic stroke. Here, we evaluated plasma sLOX‐1 levels and vascular carotid plaque LOX‐1 (ie, OLR1) gene expression in patients with ischemic stroke and…

  11. Journal Article

    NEIL3-deficiency increases gut permeability and contributes to a pro-atherogenic metabolic phenotype

    Tom Rune Karlsen; Xiang Yi Kong; Sverre Holm et al.

    Scientific Reports, Vol. 11 No. 1 · 2021 · English · DOAJ Scopus

    Abstract Atherosclerosis and its consequences cause considerable morbidity and mortality world-wide. We have previously shown that expression of the DNA glycosylase NEIL3 is regulated in human atherosclerotic plaques, and that NEIL3-deficiency enhances atherogenesis in Apoe −/− mice. Herein, we…

  12. Journal Article

    Legumain in Acute Coronary Syndromes: A Substudy of the PLATO (Platelet Inhibition and Patient Outcomes) Trial

    Ida Gregersen; Annika E. Michelsen; Ngoc Nguyen Lunde et al.

    Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol. 9 No. 17 · 2020 · English · DOAJ Scopus

    Background The cysteine protease legumain is increased in patients with atherosclerosis, but its causal role in atherogenesis and cardiovascular disease is still unclear. The aim of the study was to investigate the association of legumain with clinical outcome in a large cohort of patients with…

  13. Journal Article

    Rifaximin or Saccharomyces boulardii in heart failure with reduced ejection fraction: Results from the randomized GutHeart trial

    Ayodeji Awoyemi; Cristiane Mayerhofer; Alex S Felix et al.

    EBioMedicine, Vol. 70 · 2021 · English · DOAJ Scopus

    Background: The gut microbiota represents a potential treatment target in heart failure (HF) through microbial metabolites such as trimethylamine N-oxide (TMAO) and systemic inflammation. Treatment with the probiotic yeast Saccharomyces boulardii have been suggested to improve left ventricular…

  14. Journal Article

    Cholesterol crystals use complement to increase NLRP3 signaling pathways in coronary and carotid atherosclerosis

    Nathalie Niyonzima; Siril S. Bakke; Ida Gregersen et al.

    EBioMedicine, Vol. 60 · 2020 · English · DOAJ Scopus

    Background: During atherogenesis, cholesterol precipitates into cholesterol crystals (CC) in the vessel wall, which trigger plaque inflammation by activating the NACHT, LRR and PYD domains-containing protein 3 (NLRP3) inflammasome. We investigated the relationship between CC, complement and NLRP3…

  15. Journal Article

    T cells with increased responsiveness cause obesity in mice without diet intervention

    Ida Gregersen; Xiang Y. Kong; Sander Kooijman et al.

    iScience, Vol. 27 No. 4 · 2024 · English · DOAJ Scopus

    Summary: Obesity is a complex multicausal disease that can cause morbidity and mortality, and there is need for improved knowledge on the underlying mechanisms. Using a mouse model of increased T cell responsiveness, we show that development of obesity can be driven by immune cells. This was…

  16. Journal Article

    IL-6 Receptor Inhibition by Tocilizumab Attenuated Expression of C5a Receptor 1 and 2 in Non-ST-Elevation Myocardial Infarction

    Hilde L. Orrem; Per H. Nilsson; Søren E. Pischke et al.

    Frontiers in Immunology, Vol. 9 · 2018 · English · DOAJ Scopus

    Background: Elevated interleukin-6 (IL-6) and complement activation are associated with detrimental effects of inflammation in coronary artery disease (CAD). The complement anaphylatoxins C5a and C3a interact with their receptors; the highly inflammatory C5aR1, and the C5aR2 and C3aR. We evaluated…

  17. Journal Article

    Altered amyloid plasma profile in patients with disabling headaches after SARS-CoV-2 infection and vaccination

    Thor Ueland; Pål Aukrust; Anne Christine Poole et al.

    BMJ Neurology Open, Vol. 7 No. 2 · 2025 · English · DOAJ Scopus

    Background and objectives Persistent headache has emerged as a symptom following acute COVID-19 and, to a lesser extent, after SARS-CoV-2 vaccination. However, the underlying mechanisms remain poorly understood. This study aimed to evaluate plasma levels of amyloid-related biomarkers in patients…